Singapore markets close in 3 hours 42 minutes
Straits Times Index
3,292.16 +26.21 (+0.80%) Nikkei
38,214.98 +141.00 (+0.37%) Hang Seng
18,893.13 +355.32 (+1.92%) FTSE 100
8,381.35 +27.30 (+0.33%) Bitcoin USD
62,795.35 +1,246.95 (+2.03%) CMC Crypto 200
1,352.57 +52.47 (+4.04%)
Vertex Pharmaceuticals Incorporated (0QZU.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 07:05PM BST
| Previous close | 423.48 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 2,907 |
| Market cap | 1.076B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 0.44 |
| EPS (TTM) | 9.48 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
Simply Wall St.Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
GuruFocus.comDecoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning
© 2024 Yahoo. All rights reserved.